Back |
home / stock / embi / embi message board
Subject | By | Source | When |
---|---|---|---|
Most of these companies have massive dilution. Id | Vinpat | investorshub | 02/13/2020 9:07:48 PM |
Massive dilution. | willlbone | investorshub | 02/13/2020 8:37:07 PM |
Volume drop. | willlbone | investorshub | 02/13/2020 3:00:22 PM |
News: $EMBI Emerald Bioscience Announces $2.0 Million Registered | whytestocks | investorshub | 11/21/2019 2:30:49 PM |
News: $EMBI Glauconix Biosciences and University of Mississippi | whytestocks | investorshub | 10/03/2019 1:00:34 PM |
well quite a day! 4 times average volume | newguy49 | investorshub | 09/23/2019 11:12:43 PM |
A little news. | newguy49 | investorshub | 05/29/2019 5:35:58 PM |
I've been in it for awhile. I am | Shane96720 | investorshub | 05/26/2019 6:18:22 PM |
picked up some more shares today but judging | newguy49 | investorshub | 05/15/2019 1:13:39 AM |
Emerald Bioscience, Inc. Announces DEA Decision that its | Vector93 | investorshub | 04/01/2019 12:30:19 PM |
Damn, when this stock drops it's like a | rocco_p_coletrain | investorshub | 03/27/2019 7:33:57 PM |
Vector93, pretty sure you are right, it has | newguy49 | investorshub | 03/27/2019 5:59:10 PM |
News, Short Squeeze, Breakout and More Instantly...
Emerald Bioscience Inc Company Name:
EMBI Stock Symbol:
OTCMKTS Market:
San Diego, Calif., March 08, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE” or the “Company”), a biopharmaceutical company focused on developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with s...
San Diego, Calif., March 03, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE” or the “Company”), a biopharmaceutical company focused on developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with s...
San Diego, Calif., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE” or the “Company”), a biopharmaceutical company focused on developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with si...